Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non-small cell lung carcinoma
Background Thyroid transcription factor (TTF-1) is a diagnostic marker expressed in 75%-85% of primary lung adenocarcinomas (ACs). Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene is the most common targetable driver alteration in lung AC. Previo...
Saved in:
Main Authors: | Tripti Nakra (Author), Varsha Singh (Author), Aruna Nambirajan (Author), Prabhat Singh Malik (Author), Anant Mohan (Author), Deepali Jain (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
by: Priyanka Singh, et al.
Published: (2022) -
EGFR mutation testing in non-small cell lung cancer (NSCLC)
by: Fouad Al Dayel
Published: (2012) -
Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis
by: Naga Jyothi Meka, et al.
Published: (2015) -
Clinical and surgical implications of EGFR mutations in non-small cell lung cancer
by: M. Yoon, et al.
Published: (2016) -
Non-small-cell lung cancer: how to manage EGFR-mutated disease
by: Federica Pecci, et al.
Published: (2022)